Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001079973-23-000523
Filing Date
2023-04-24
Accepted
2023-04-24 16:45:37
Documents
61

Document Format Files

Seq Description Document Type Size
1 POST-EFFECTIVE AMENDMENT NO 1 TO FORM S-1 cdio_posam.htm   iXBRL POS AM 1846534
2 EXHIBIT 23.1 ex23x1.htm EX-23.1 2307
3 GRAPHIC image_001.jpg GRAPHIC 3552
4 GRAPHIC image_002.jpg GRAPHIC 12270
5 GRAPHIC image_003.jpg GRAPHIC 29560
6 GRAPHIC image_004.jpg GRAPHIC 35141
7 GRAPHIC image_005.jpg GRAPHIC 39421
8 GRAPHIC image_006.jpg GRAPHIC 10255
9 GRAPHIC image_007.jpg GRAPHIC 35818
10 GRAPHIC image_008.jpg GRAPHIC 35883
  Complete submission text file 0001079973-23-000523.txt   4981172

Data Files

Seq Description Document Type Size
11 XBRL SCHEMA FILE cdio-20221231.xsd EX-101.SCH 30585
12 XBRL CALCULATION FILE cdio-20221231_cal.xml EX-101.CAL 38083
13 XBRL DEFINITION FILE cdio-20221231_def.xml EX-101.DEF 78358
14 XBRL LABEL FILE cdio-20221231_lab.xml EX-101.LAB 228659
15 XBRL PRESENTATION FILE cdio-20221231_pre.xml EX-101.PRE 175641
55 EXTRACTED XBRL INSTANCE DOCUMENT cdio_posam_htm.xml XML 288913
Mailing Address 400 N ABERDEEN ST, SUITE 900 CHICAGO IL 60642
Business Address 400 N ABERDEEN ST, SUITE 900 CHICAGO IL 60642 855-226-9991
Cardio Diagnostics Holdings, Inc. (Filer) CIK: 0001870144 (see all company filings)

IRS No.: 870925574 | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-268759 | Film No.: 23840638
SIC: 2835 In Vitro & In Vivo Diagnostic Substances